ARTICLE | Company News
Dainippon seeks blonanserin approval in China
September 28, 2013 1:00 AM UTC
Dainippon Sumitomo Pharma Co. Ltd. (Tokyo:4506; Osaka:4506) submitted an imported drug registration application to the China Food and Drug Administration (CFDA) for blonanserin to treat schizophrenia....